A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Emory University
Emory University
Memorial Sloan Kettering Cancer Center
Laboratorio Elea Phoenix S.A.
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Samsung Medical Center